We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$19.4B
AUM Growth
+$2.92B
Cap. Flow
+$1.81B
Cap. Flow %
9.31%
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$694M
2
PM icon
Philip Morris
PM
+$316M
3
JNJ icon
Johnson & Johnson
JNJ
+$315M
4
MRK icon
Merck
MRK
+$303M
5
APC
Anadarko Petroleum
APC
+$235M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$248M
2
MU icon
Micron Technology
MU
+$212M
3
RAD
Rite Aid Corporation
RAD
+$196M
4
CMCSA icon
Comcast
CMCSA
+$165M
5
GSK icon
GSK
GSK
+$149M

Sector Composition

Rank Sector Weight
1 Technology 20.45%
2 Energy 18.88%
3 Healthcare 17.92%
4 Financials 10.19%
5 Consumer Staples 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OME
1301
DELISTED
Omega Protein
OME
-23,455
Closed -$283K
CBF
1302
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
-97,830
Closed -$2.46M
LVLT
1303
DELISTED
Level 3 Communications Inc
LVLT
-54,129
Closed -$2.12M
ALR
1304
DELISTED
Alere Inc
ALR
-234,745
Closed -$8.06M
PRXL
1305
DELISTED
Parexel International Corp
PRXL
-37,935
Closed -$2.05M
WFM
1306
DELISTED
Whole Foods Market Inc
WFM
-351,514
Closed -$17.8M
ALJ
1307
DELISTED
Alon USA Energy Inc
ALJ
-28,531
Closed -$426K
EVER
1308
DELISTED
Everbank Financial Corp
EVER
-83,673
Closed -$1.65M
VAL
1309
DELISTED
Valspar
VAL
-25,358
Closed -$1.83M
TPLM
1310
DELISTED
Triangle Petroleum Corporation
TPLM
-11,912
Closed -$98K
EQY
1311
DELISTED
Equity One
EQY
-148,837
Closed -$3.33M
ELNK
1312
DELISTED
EarthLink Holdings Corp.
ELNK
-844,189
Closed -$3.05M
CLMS
1313
DELISTED
Calamos Asset Management, Inc.
CLMS
-27,394
Closed -$354K
TMH
1314
DELISTED
Team Health Holdings Inc
TMH
-48,782
Closed -$2.18M
STJ
1315
DELISTED
St Jude Medical
STJ
-5,225
Closed -$342K
LGF
1316
DELISTED
Lions Gate Entertainment
LGF
-63,270
Closed -$1.69M
BLOX
1317
DELISTED
Infoblox Inc
BLOX
-255,924
Closed -$5.13M
SQI
1318
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
-73,708
Closed -$1.99M
EXAM
1319
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
-127,848
Closed -$4.48M
RSE
1320
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
-48,010
Closed -$828K
UNTD
1321
DELISTED
UNITED ONLINE INC COM NEW
UNTD
-98,754
Closed -$1.14M
CKP
1322
DELISTED
CHECKPOINT SYSTEMS INC
CKP
-50,016
Closed -$671K
ORIG
1323
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
-29
Closed -$4.76M
ATML
1324
DELISTED
ATMEL CORP
ATML
-62,385
Closed -$522K
RJET
1325
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
-77,220
Closed -$706K

Similar funds

Arrowstreet Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.

  • Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
  • Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
  • Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
  • Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
  • Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
  • Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
  • Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.

Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.